Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 26, 2022
Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose <sup>211</sup>At-Labeled Anti-HER2 Single-Domain Antibody FragmentYutian Feng, Rebecca Meshaw, Xiao-Guang Zhao, et al.
Nuclear Medicine and Biology|October 9, 2007
Targeted alpha-particle radiotherapy with 211At-labeled monoclonal antibodiesMichael R Zalutsky, David A Reardon, Oscar R Pozzi, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 29, 2020
Labeling Monoclonal Antibody with α-emitting <sup>211</sup>At at High Activity Levels via a Tin PrecursorGanesan Vaidyanathan, Oscar R Pozzi, Jaeyeon Choi, et al.
Nuclear Medicine and Biology|November 20, 2012
Targeting breast carcinoma with radioiodinated anti-HER2 NanobodyMarek Pruszynski, Eftychia Koumarianou, Ganesan Vaidyanathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Specific and high-level targeting of radiolabeled octreotide analogues to human medulloblastoma xenograftsGanesan Vaidyanathan, Henry S Friedman, Donna J Affleck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2004
A 4-methyl-substituted meta-iodobenzylguanidine analogue with prolonged retention in human neuroblastoma cellsGanesan Vaidyanathan, Philip C Welsh, Katia C Vitorello, et al.
International Journal of Nanomedicine|November 5, 2021
Gold Nanostars: A Novel Platform for Developing <sup>211</sup>At-Labeled Agents for Targeted Alpha-Particle TherapyYang Liu, Zhengyuan Zhou, Yutian Feng, et al.
European Journal of Medicinal Chemistry|October 29, 2013
Investigation of nuclease, proteolytic and antiproliferative effects of copper(II) complexes of thiophenylmethanamine derivativesSubramaniyam Rajalakshmi, Manikantan Syamala Kiran, Vaidyanathan Ganesan Vaidyanathan, et al.
Pageof 9